These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9547584)

  • 41. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
    Treeck O; Lattrich C; Springwald A; Ortmann O
    Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors.
    Cohen LA; Marks PA; Rifkind RA; Amin S; Desai D; Pittman B; Richon VM
    Anticancer Res; 2002; 22(3):1497-504. PubMed ID: 12168829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells.
    Oft M; Peli J; Rudaz C; Schwarz H; Beug H; Reichmann E
    Genes Dev; 1996 Oct; 10(19):2462-77. PubMed ID: 8843198
    [TBL] [Abstract][Full Text] [Related]  

  • 44. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.
    Morrison BW; Leder P
    Oncogene; 1994 Dec; 9(12):3417-26. PubMed ID: 7970700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of treatment of rats with indole-3-carbinol on apoptosis in the mammary gland and mammary adenocarcinomas.
    Zhang X; Malejka-Giganti D
    Anticancer Res; 2003; 23(3B):2473-9. PubMed ID: 12894530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine.
    Unni E; Kittrell FS; Singh U; Sinha R
    Breast Cancer Res; 2004; 6(5):R586-92. PubMed ID: 15318939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis.
    Cabanes A; Wang M; Olivo S; DeAssis S; Gustafsson JA; Khan G; Hilakivi-Clarke L
    Carcinogenesis; 2004 May; 25(5):741-8. PubMed ID: 14729590
    [TBL] [Abstract][Full Text] [Related]  

  • 48. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations.
    D'Cruz CM; Gunther EJ; Boxer RB; Hartman JL; Sintasath L; Moody SE; Cox JD; Ha SI; Belka GK; Golant A; Cardiff RD; Chodosh LA
    Nat Med; 2001 Feb; 7(2):235-9. PubMed ID: 11175856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
    Kyprianou N; Isaacs JT
    Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of indole-3-carbinol on steroid hormone profile and tumor progression in a mice model of canine inflammatory mammarycancer.
    Martín-Ruiz A; Peña L; González-Gil A; Díez-Córdova LT; Cáceres S; Illera JC
    BMC Cancer; 2018 Jun; 18(1):626. PubMed ID: 29866056
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective responsiveness of human breast cancer cells to indole-3-carbinol, a chemopreventive agent.
    Tiwari RK; Guo L; Bradlow HL; Telang NT; Osborne MP
    J Natl Cancer Inst; 1994 Jan; 86(2):126-31. PubMed ID: 8271295
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor.
    Zajchowski DA; Sager R; Webster L
    Cancer Res; 1993 Oct; 53(20):5004-11. PubMed ID: 8402691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carcinoma induction following direct in situ transfer of v-Ha-ras into rat mammary epithelial cells using replication-defective retrovirus vectors.
    Wang BC; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
    Cancer Res; 1991 May; 51(10):2642-8. PubMed ID: 2021942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Indole-3-carbinol. A novel approach to breast cancer prevention.
    Bradlow HL; Sepkovic DW; Telang NT; Osborne MP
    Ann N Y Acad Sci; 1995 Sep; 768():180-200. PubMed ID: 8526347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene.
    Lebeau J; Le Chalony C; Prosperi MT; Goubin G
    Oncogene; 1991 Jul; 6(7):1125-32. PubMed ID: 1861862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.
    Wang Y; Thakur A; Sun Y; Wu J; Biliran H; Bollig A; Liao DJ
    Cancer Res; 2007 Apr; 67(8):3698-707. PubMed ID: 17440082
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ha-ras and v-raf oncogenes, but not int-2 and c-myc, interfere with the lactogenic hormone dependent activation of the mammary gland specific transcription factor.
    Happ B; Hynes NE; Groner B
    Cell Growth Differ; 1993 Jan; 4(1):9-15. PubMed ID: 8424907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Eugenol restricts DMBA croton oil induced skin carcinogenesis in mice: downregulation of c-Myc and H-ras, and activation of p53 dependent apoptotic pathway.
    Pal D; Banerjee S; Mukherjee S; Roy A; Panda CK; Das S
    J Dermatol Sci; 2010 Jul; 59(1):31-9. PubMed ID: 20537511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor rejection antigens on BALB3T3 cells transformed by activated oncogenes.
    Torigoe T; Sato N; Takashima T; Cho JM; Tsuboi N; Qi WM; Hara I; Wada Y; Takahashi N; Kikuchi K
    J Immunol; 1991 Nov; 147(9):3251-8. PubMed ID: 1919013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.
    Kim SH; Nakagawa H; Navaraj A; Naomoto Y; Klein-Szanto AJ; Rustgi AK; El-Deiry WS
    Cancer Res; 2006 Nov; 66(21):10415-24. PubMed ID: 17079462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.